Navigation Links
ACT Genomics Raises $8 Million in its First Private Funding Round
Date:2/13/2015

TAIPEI, Feb. 13, 2015 /PRNewswire/ -- ACT Genomics Co., Ltd., a cancer molecular information service company that aims to transform cancer genomic information into precision diagnosis and personalized treatments, today announced that the company has raised US$ 8 million in the its first private funding round.

Based in Taipei, Taiwan, ACT Genomics has developed comprehensive cancer diagnostic tests, ACTDrug™, ACTOnco™. With the aim to implement next generation sequencing (NGS) and multiplex molecular testing platforms to analyze a variety of clinical specimens (i.e., formalin fixed paraffin-embedded tumor tissue, frozen tissue, circulating tumor cells, and purified DNA), the scientists and medical team can accurately detect tumor genomic alternations in more than 400 cancer-related genes, and transform the information into tailored cancer treatments. With advanced next generation sequencing (NGS) and multiplex molecular testing platform, coupling with proprietary bioinformatics engines for clinical reporting, ACT Genomics is capable of providing accurate genomic data and comprehensive interpretation to address key challenges in cancer treatment - "Precision Medicine".

The funding will support the further investment in ACT Genomics' new portfolio of molecular diagnostic assays that can help physicians to address issues in cancer monitoring as well as the expansion of sales, marketing and medical team, the company said in a statement.

Dr. Hua-Chien Chen, the CEO said, "We are very pleased to have completed our first private funding. The R&D progress we made in the past 6 months has impressed the existing and new investors. The additional capital will allow us to continue building robust molecular assays and innovative bioinformatics engine to integrate genome guided medicine database. In addition, we see a significant market opportunity and unmet medical needs for ACT Genomics' cancer diagnostic tests, this round of capital will allow us to expand our team and ultimately to contribute to improve cancer patients' clinical outcomes."

ACT Genomics Contact:

PJ (Joe) Hsueh, MBA, Chief Operating Officer
Email: pjhsueh@actgenomics.com

Angus Wu, Vice Director, Business Development
Email: anguswu@actgenomics.com


'/>"/>
SOURCE ACT Genomics
Copyright©2015 PR Newswire.
All rights reserved

Related biology news :

1. Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine
2. The Genome Institute at Washington University Receives Irys System from BioNano Genomics to Advance Research for Genome Reference Consortium
3. Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
4. Tute Genomics Launches MyGene Portal for Genome-guided Medicine
5. From the basics to the cutting edge of molecular biology and genomics in one small book
6. BGI Tech launches human whole exome sequencing service on complete genomics advanced platform
7. Eurofins Genomics and AmpTec close distribution agreement for very long synthetic RNAs
8. Structural Genomics Consortium and CHDI Foundation announce new partnership
9. The first termite genome fills a gap in social inset genomics
10. Charismatic organisms still dominating genomics research
11. Pharmocogenomics has not fulfilled its promise to developing countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2019)... ... May 21, 2019 , ... Suvoda LLC , a SaaS provider ... has been named one of Inc. Magazine’s Best Workplaces for 2019, Inc.’s fourth annual ... featured on Inc.com and hitting the newsstands on May 28, is the result of ...
(Date:5/21/2019)... BOSTON (PRWEB) , ... May 21, 2019 , ... At ... Engineered Constructs for Tissue Engineered Medical Products (TEMPs) of the American Society for ... Asymmetrex . Gaining this approval was the next step in the company’s ...
(Date:5/14/2019)... Calif. (PRWEB) , ... May 13, 2019 , ... ... on Tuesday, June 4th, at a very special Pre-EWMA 2019 event at Gothenburg’s ... on the latest Trends, Opportunities and Innovations in Advanced Wound Care. , SmartTRAK’s ...
Breaking Biology News(10 mins):
(Date:4/25/2019)... ... April 24, 2019 , ... Inference Solutions ... service organizations, today announced global availability of Inference Studio’s latest version, which makes ... sizes to harness the power of Google’s Contact Center AI (CCAI). ...
(Date:4/15/2019)... ... April 15, 2019 , ... Sirrus, ... a $2 million bench plant expansion to increase production of methylene malonate monomers ... design and construction of Sirrus’ full-scale production facility, which is scheduled to break ...
(Date:4/9/2019)... ... 09, 2019 , ... USDM Life Sciences , the ... organizations to accelerate innovation and maximize productivity, announces that nearly 100 companies have ... , USDM’s Cloud Assurance is a managed subscription service delivering end-to-end ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global ... $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). ... Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to begin ...
Breaking Biology Technology: